DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa (Apixaban) and INVICTUS (Rivaroxaban).

Authors	Rachel Ryu
Journal	Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (Clin Appl Thromb Hemost) 2022 Jan-Dec Vol. 28 Pg. 10760296221144044 ISSN: 1938-2723 [Electronic] United States
PMID	36474349 (Publication Type: Letter, Comment)
Chemical References	Rivaroxaban
Topics	Humans Rivaroxaban (therapeutic use) Heart Valve Diseases (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!